Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Squamous Cell Carcinoma of Head and Neck × Doxorubicin × 90 days × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 21 Burkitt Lymphoma 12 Breast Neoplasms 11 Neoplasms 10 Lymphoma, Follicular 10 Lymphoma 9 Triple Negative Breast Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Sarcoma 7 Ovarian Neoplasms 6 Hodgkin Disease 6 Endometrial Neoplasms 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, B-Cell 5 Sarcoma, Ewing 4 Recurrence 4 Osteosarcoma 4 Neuroblastoma 4 Neoplasm Metastasis 4 Lymphoma, Non-Hodgkin 4 Lymphoma, Mantle-Cell 4 Liposarcoma 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Fallopian Tube Neoplasms 4 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Biphenotypic, Acute 3 Leiomyosarcoma 3 Inflammatory Breast Neoplasms 3 Ganglioneuroblastoma 3 Urinary Bladder Neoplasms 2

Interventions

pembrolizumab 55 Cisplatin 35 Cetuximab 26 Carboplatin 24 Radiotherapy 18 Radiotherapy, Intensity-Modulated 17 Magnetic Resonance Spectroscopy 16 Specimen Handling 14 Paclitaxel 14 Nivolumab 14 Docetaxel 14 Platinum 8 Fluorouracil 8 1,2-diaminocyclohexaneplatinum II citrate 8 Biopsy 6 (225)Ac-DOTA-c(RGDyK) 6 atezolizumab 5 Radiation 5 Ipilimumab 5 Drug Therapy 5 durvalumab 4 cemiplimab 4 Taxes 4 Standard of Care 4 Radiosurgery 4 Immunoglobulin G 4 Immune Checkpoint Inhibitors 4 Cyclophosphamide 4 Chemoradiotherapy 4 toripalimab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡